By MICHAEL J. DE LA MERCED
Valeant Pharmaceuticals announced a sweetened bid for Allergan on Friday, only two days after increasing its offer for the maker of Botox. The drug maker is now offering $72 a share in cash.
Published: May 30, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1rq2yaQ
from WordPress http://ift.tt/1oSxlJ3
via Hadi Aboukhater
No comments:
Post a Comment